DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)

This site is published by Janssen Biotech, Inc., which is solely responsible for its contents. The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.

This information is intended for the use of patients and caregivers in the United States and Puerto Rico only. Laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States and Puerto Rico.

Third party trademarks used herein are trademarks of their respective owners.

Sitemap

About Multiple Myeloma

About DARZALEX FASPRO^®

Results With DARZALEX FASPRO^®

Living With Multiple Myeloma

Treatment and Cost Support